Difference between revisions of "Role of ubiquitination"

From Aging Chart
Jump to: navigation, search
(Autoloading by CXLParser)
(Autoloading by CXLParser)
Line 1: Line 1:
 
<!-- It is graph description -->
 
<!-- It is graph description -->
 
<graphviz renderer='neato' >
 
<graphviz renderer='neato' >
digraph {
+
digraph {splines=spline;
size ="25.56,15.82";
+
splines=spline;
+
 
overlap=scale;
 
overlap=scale;
 
"1J1D8B0LY-77N6FX-5FN" [id="1J1D8B0LY-77N6FX-5FN",
 
"1J1D8B0LY-77N6FX-5FN" [id="1J1D8B0LY-77N6FX-5FN",
Line 567: Line 565:
 
(.//.)<html><!--Pop-up for: Methylglyoxal !Pop-up-->
 
(.//.)<html><!--Pop-up for: Methylglyoxal !Pop-up-->
 
<div class="1J1D8B0LY-77N6FX-5FN" style="display:none;">
 
<div class="1J1D8B0LY-77N6FX-5FN" style="display:none;">
 +
  
  
Line 573: Line 572:
 
</div>(...)<!--Pop-up for: E2F !Pop-up-->
 
</div>(...)<!--Pop-up for: E2F !Pop-up-->
 
<div class="1HXDY3N30-SXZ26V-89M" style="display:none;">
 
<div class="1HXDY3N30-SXZ26V-89M" style="display:none;">
 +
  
  
Line 579: Line 579:
 
</div>(...)<!--Pop-up for: Ras !Pop-up-->
 
</div>(...)<!--Pop-up for: Ras !Pop-up-->
 
<div class="1HXF3TMQM-73NBC5-FW0" style="display:none;">
 
<div class="1HXF3TMQM-73NBC5-FW0" style="display:none;">
 +
  
  
Line 585: Line 586:
 
</div>(...)<!--Pop-up for: ATR !Pop-up-->
 
</div>(...)<!--Pop-up for: ATR !Pop-up-->
 
<div class="1N9P66C3N-1KWKJKJ-1ZB3" style="display:none;">
 
<div class="1N9P66C3N-1KWKJKJ-1ZB3" style="display:none;">
 +
  
  
Line 591: Line 593:
 
</div>(...)<!--Pop-up for: Proliferation !Pop-up-->
 
</div>(...)<!--Pop-up for: Proliferation !Pop-up-->
 
<div class="1HXF3W5MJ-D3H95R-FXG" style="display:none;">
 
<div class="1HXF3W5MJ-D3H95R-FXG" style="display:none;">
 +
  
  
Line 597: Line 600:
 
</div>(...)<!--Pop-up for: Poliubiquitination of  Ubiquitin ligase CHIP by E3 !Pop-up-->
 
</div>(...)<!--Pop-up for: Poliubiquitination of  Ubiquitin ligase CHIP by E3 !Pop-up-->
 
<div class="1J1D8K6B5-17RSFTK-5JW" style="display:none;">
 
<div class="1J1D8K6B5-17RSFTK-5JW" style="display:none;">
 +
  
  
Line 603: Line 607:
 
</div>(...)<!--Pop-up for: Availability of damaged DNA For repair complexes !Pop-up-->
 
</div>(...)<!--Pop-up for: Availability of damaged DNA For repair complexes !Pop-up-->
 
<div class="1HXDX8QW4-8CH6YX-7M9" style="display:none;">
 
<div class="1HXDX8QW4-8CH6YX-7M9" style="display:none;">
 +
  
  
Line 609: Line 614:
 
</div>(...)<!--Pop-up for: Transcription of adaptation  to hypoxia genes !Pop-up-->
 
</div>(...)<!--Pop-up for: Transcription of adaptation  to hypoxia genes !Pop-up-->
 
<div class="1HXLM05XC-1FSPCXC-17T" style="display:none;">
 
<div class="1HXLM05XC-1FSPCXC-17T" style="display:none;">
 +
  
  
Line 615: Line 621:
 
</div>(...)<!--Pop-up for: FOXO1 deacetylation !Pop-up-->
 
</div>(...)<!--Pop-up for: FOXO1 deacetylation !Pop-up-->
 
<div class="1J2TTSY2L-Z3PR1X-12T" style="display:none;">
 
<div class="1J2TTSY2L-Z3PR1X-12T" style="display:none;">
 +
  
  
Line 621: Line 628:
 
</div>(...)<!--Pop-up for: EGF-R !Pop-up-->
 
</div>(...)<!--Pop-up for: EGF-R !Pop-up-->
 
<div class="1HXF3TF9N-2CNRBZM-FVR" style="display:none;">
 
<div class="1HXF3TF9N-2CNRBZM-FVR" style="display:none;">
 +
  
  
Line 627: Line 635:
 
</div>(...)<!--Pop-up for: Ubiquitination and proteasome  Degradation of p21 and p27 !Pop-up-->
 
</div>(...)<!--Pop-up for: Ubiquitination and proteasome  Degradation of p21 and p27 !Pop-up-->
 
<div class="1HXF1DZW9-1N3N3CF-CCH" style="display:none;">
 
<div class="1HXF1DZW9-1N3N3CF-CCH" style="display:none;">
 +
  
  
Line 633: Line 642:
 
</div>(...)<!--Pop-up for: E3 ubiquitin ligase complex  Rad6-Rad18 !Pop-up-->
 
</div>(...)<!--Pop-up for: E3 ubiquitin ligase complex  Rad6-Rad18 !Pop-up-->
 
<div class="1HXDYCP8F-2BZCX14-8VY" style="display:none;">
 
<div class="1HXDYCP8F-2BZCX14-8VY" style="display:none;">
 +
  
  
Line 639: Line 649:
 
</div>(...)<!--Pop-up for: PCNA !Pop-up-->
 
</div>(...)<!--Pop-up for: PCNA !Pop-up-->
 
<div class="1HXDYPJ1C-RC1Z03-8X5" style="display:none;">
 
<div class="1HXDYPJ1C-RC1Z03-8X5" style="display:none;">
 +
  
  
Line 645: Line 656:
 
</div>(...)<!--Pop-up for: Ubiquitination and proteasome  Degradation of HIF-1a !Pop-up-->
 
</div>(...)<!--Pop-up for: Ubiquitination and proteasome  Degradation of HIF-1a !Pop-up-->
 
<div class="1HXLLVYXK-YD59DQ-15R" style="display:none;">
 
<div class="1HXLLVYXK-YD59DQ-15R" style="display:none;">
 +
  
  
Line 651: Line 663:
 
</div>(...)<!--Pop-up for: DNA damage !Pop-up-->
 
</div>(...)<!--Pop-up for: DNA damage !Pop-up-->
 
<div class="1HXDXCP6L-1JPNVC5-7R3" style="display:none;">
 
<div class="1HXDXCP6L-1JPNVC5-7R3" style="display:none;">
 +
  
  
Line 657: Line 670:
 
</div>(...)<!--Pop-up for: Monoubiquitination by ligase Cbl !Pop-up-->
 
</div>(...)<!--Pop-up for: Monoubiquitination by ligase Cbl !Pop-up-->
 
<div class="1HXF3XKMD-1MDXYWM-FZ1" style="display:none;">
 
<div class="1HXF3XKMD-1MDXYWM-FZ1" style="display:none;">
 +
  
  
Line 663: Line 677:
 
</div>(...)<!--Pop-up for: ATP-dependent  Chromatin remodeling !Pop-up-->
 
</div>(...)<!--Pop-up for: ATP-dependent  Chromatin remodeling !Pop-up-->
 
<div class="1HXDX70DD-C3RG63-7L2" style="display:none;">
 
<div class="1HXDX70DD-C3RG63-7L2" style="display:none;">
 +
  
  
Line 669: Line 684:
 
</div>(...)<!--Pop-up for: Ubiquitination and proteasome  Degradation of FOXO1 !Pop-up-->
 
</div>(...)<!--Pop-up for: Ubiquitination and proteasome  Degradation of FOXO1 !Pop-up-->
 
<div class="1J2TTVWV5-1XB3QXN-15M" style="display:none;">
 
<div class="1J2TTVWV5-1XB3QXN-15M" style="display:none;">
 +
  
  
Line 675: Line 691:
 
</div>(...)<!--Pop-up for: DNA repair !Pop-up-->
 
</div>(...)<!--Pop-up for: DNA repair !Pop-up-->
 
<div class="1HXDZ4FX8-1VG5BFM-92S" style="display:none;">
 
<div class="1HXDZ4FX8-1VG5BFM-92S" style="display:none;">
 +
  
  
Line 681: Line 698:
 
</div>(...)<!--Pop-up for: Normoxia !Pop-up-->
 
</div>(...)<!--Pop-up for: Normoxia !Pop-up-->
 
<div class="1HXLLS50M-1PPGMX8-11F" style="display:none;">
 
<div class="1HXLLS50M-1PPGMX8-11F" style="display:none;">
 +
  
  
Line 687: Line 705:
 
</div>(...)<!--Pop-up for: PCNA !Pop-up-->
 
</div>(...)<!--Pop-up for: PCNA !Pop-up-->
 
<div class="1N9P5YMFF-15HT175-1Z1Z" style="display:none;">
 
<div class="1N9P5YMFF-15HT175-1Z1Z" style="display:none;">
 +
  
  
Line 693: Line 712:
 
</div>(...)<!--Pop-up for: ARF !Pop-up-->
 
</div>(...)<!--Pop-up for: ARF !Pop-up-->
 
<div class="1HXF0TXZ0-2BJ3NZN-BJY" style="display:none;">
 
<div class="1HXF0TXZ0-2BJ3NZN-BJY" style="display:none;">
 +
  
  
Line 699: Line 719:
 
</div>(...)<!--Pop-up for: Disturbance of tissue resistance to hypoxia !Pop-up-->
 
</div>(...)<!--Pop-up for: Disturbance of tissue resistance to hypoxia !Pop-up-->
 
<div class="1J1D8PQ19-MN9P7R-5P6" style="display:none;">
 
<div class="1J1D8PQ19-MN9P7R-5P6" style="display:none;">
 +
  
  
Line 705: Line 726:
 
</div>(...)<!--Pop-up for: Ubiquitination and proteasomal  Degradation of hTERT !Pop-up-->
 
</div>(...)<!--Pop-up for: Ubiquitination and proteasomal  Degradation of hTERT !Pop-up-->
 
<div class="1HXDZVLBH-HRNZM1-9PT" style="display:none;">
 
<div class="1HXDZVLBH-HRNZM1-9PT" style="display:none;">
 +
  
  
Line 711: Line 733:
 
</div>(...)<!--Pop-up for: Cell proliferation !Pop-up-->
 
</div>(...)<!--Pop-up for: Cell proliferation !Pop-up-->
 
<div class="1HXF261VH-3SS0BX-D11" style="display:none;">
 
<div class="1HXF261VH-3SS0BX-D11" style="display:none;">
 +
  
  
Line 717: Line 740:
 
</div>(...)<!--Pop-up for: SIRT1 !Pop-up-->
 
</div>(...)<!--Pop-up for: SIRT1 !Pop-up-->
 
<div class="1J2TTSH03-9498TK-12B" style="display:none;">
 
<div class="1J2TTSH03-9498TK-12B" style="display:none;">
 +
  
  
Line 723: Line 747:
 
</div>(...)<!--Pop-up for: MAPK !Pop-up-->
 
</div>(...)<!--Pop-up for: MAPK !Pop-up-->
 
<div class="1HXF3TW1Q-23JXDZC-FWS" style="display:none;">
 
<div class="1HXF3TW1Q-23JXDZC-FWS" style="display:none;">
 +
  
  
Line 729: Line 754:
 
</div>(...)<!--Pop-up for: Cyclin E/Cdk2 !Pop-up-->
 
</div>(...)<!--Pop-up for: Cyclin E/Cdk2 !Pop-up-->
 
<div class="1HXF15RQR-1KBC5BM-C6K" style="display:none;">
 
<div class="1HXF15RQR-1KBC5BM-C6K" style="display:none;">
 +
  
  
Line 735: Line 761:
 
</div>(...)<!--Pop-up for: Ubiquitination and proteasomal  Degradation of Pin2/TRF1 !Pop-up-->
 
</div>(...)<!--Pop-up for: Ubiquitination and proteasomal  Degradation of Pin2/TRF1 !Pop-up-->
 
<div class="1HXF1P942-2BF86CX-CN0" style="display:none;">
 
<div class="1HXF1P942-2BF86CX-CN0" style="display:none;">
 +
  
  
Line 741: Line 768:
 
</div>(...)<!--Pop-up for: E3 ubiquitin  Ligase complex  BRCA1/BARD1 !Pop-up-->
 
</div>(...)<!--Pop-up for: E3 ubiquitin  Ligase complex  BRCA1/BARD1 !Pop-up-->
 
<div class="1HXDX5L49-77W2CW-7HY" style="display:none;">
 
<div class="1HXDX5L49-77W2CW-7HY" style="display:none;">
 +
  
  
Line 747: Line 775:
 
</div>(...)<!--Pop-up for: E3 ubiquitin ligase VHL !Pop-up-->
 
</div>(...)<!--Pop-up for: E3 ubiquitin ligase VHL !Pop-up-->
 
<div class="1HXLLTPY9-V8MC72-153" style="display:none;">
 
<div class="1HXLLTPY9-V8MC72-153" style="display:none;">
 +
  
  
Line 753: Line 782:
 
</div>(...)<!--Pop-up for: Р53 !Pop-up-->
 
</div>(...)<!--Pop-up for: Р53 !Pop-up-->
 
<div class="1HXDXPP3Z-1K7XJS9-7ZK" style="display:none;">
 
<div class="1HXDXPP3Z-1K7XJS9-7ZK" style="display:none;">
 +
  
  
Line 759: Line 789:
 
</div>(...)<!--Pop-up for: Cyclin A/Cdk2 !Pop-up-->
 
</div>(...)<!--Pop-up for: Cyclin A/Cdk2 !Pop-up-->
 
<div class="1N9P55MTN-4H4V8F-1YRJ" style="display:none;">
 
<div class="1N9P55MTN-4H4V8F-1YRJ" style="display:none;">
 +
  
  
Line 765: Line 796:
 
</div>(...)<!--Pop-up for: ubiquitination !Pop-up-->
 
</div>(...)<!--Pop-up for: ubiquitination !Pop-up-->
 
<div class="1NLC2KCGW-SKR5JN-38F" style="display:none;">
 
<div class="1NLC2KCGW-SKR5JN-38F" style="display:none;">
 +
  
  
Line 771: Line 803:
 
</div>(...)<!--Pop-up for: Complex 9-1-1 !Pop-up-->
 
</div>(...)<!--Pop-up for: Complex 9-1-1 !Pop-up-->
 
<div class="1HXDYQ1VX-P0G5CN-8Y9" style="display:none;">
 
<div class="1HXDYQ1VX-P0G5CN-8Y9" style="display:none;">
 +
  
  
Line 777: Line 810:
 
</div>(...)<!--Pop-up for: Transcription of  proliferation genes !Pop-up-->
 
</div>(...)<!--Pop-up for: Transcription of  proliferation genes !Pop-up-->
 
<div class="1HXDY473R-160M3Z0-8C5" style="display:none;">
 
<div class="1HXDY473R-160M3Z0-8C5" style="display:none;">
 +
  
  
Line 783: Line 817:
 
</div>(...)<!--Pop-up for: Chk2 kinase !Pop-up-->
 
</div>(...)<!--Pop-up for: Chk2 kinase !Pop-up-->
 
<div class="1HXDXX01M-SPR3HQ-82K" style="display:none;">
 
<div class="1HXDXX01M-SPR3HQ-82K" style="display:none;">
 +
  
  
Line 789: Line 824:
 
</div>(...)<!--Pop-up for: XPC !Pop-up-->
 
</div>(...)<!--Pop-up for: XPC !Pop-up-->
 
<div class="1N9P5YC6Y-WZZ1KZ-1Z1D" style="display:none;">
 
<div class="1N9P5YC6Y-WZZ1KZ-1Z1D" style="display:none;">
 +
  
  
Line 795: Line 831:
 
</div>(...)<!--Pop-up for: E3 ubiquitin ligase MKRN1 !Pop-up-->
 
</div>(...)<!--Pop-up for: E3 ubiquitin ligase MKRN1 !Pop-up-->
 
<div class="1HXDZTC5L-1T2SN4H-9N1" style="display:none;">
 
<div class="1HXDZTC5L-1T2SN4H-9N1" style="display:none;">
 +
  
  
Line 801: Line 838:
 
</div>(...)<!--Pop-up for: Ligand binding !Pop-up-->
 
</div>(...)<!--Pop-up for: Ligand binding !Pop-up-->
 
<div class="1HXF413M8-1ZWD9C0-G37" style="display:none;">
 
<div class="1HXF413M8-1ZWD9C0-G37" style="display:none;">
 +
  
  
Line 807: Line 845:
 
</div>(...)<!--Pop-up for: Transition to  Cell cycle S-phase !Pop-up-->
 
</div>(...)<!--Pop-up for: Transition to  Cell cycle S-phase !Pop-up-->
 
<div class="1HXF2PNF5-T888QY-F0C" style="display:none;">
 
<div class="1HXF2PNF5-T888QY-F0C" style="display:none;">
 +
  
  
Line 813: Line 852:
 
</div>(...)<!--Pop-up for: Phosphorylation of inhibitor of cyclin-dependent  Kinases p21 and p27 !Pop-up-->
 
</div>(...)<!--Pop-up for: Phosphorylation of inhibitor of cyclin-dependent  Kinases p21 and p27 !Pop-up-->
 
<div class="1HXF16LX4-26J48HP-C7M" style="display:none;">
 
<div class="1HXF16LX4-26J48HP-C7M" style="display:none;">
 +
  
  
Line 819: Line 859:
 
</div>(...)<!--Pop-up for: DDB2 !Pop-up-->
 
</div>(...)<!--Pop-up for: DDB2 !Pop-up-->
 
<div class="1N9P5Y33L-1FNMXTX-1Z18" style="display:none;">
 
<div class="1N9P5Y33L-1FNMXTX-1Z18" style="display:none;">
 +
  
  
Line 825: Line 866:
 
</div>(...)<!--Pop-up for: Proteasome degradation of HIF-1a !Pop-up-->
 
</div>(...)<!--Pop-up for: Proteasome degradation of HIF-1a !Pop-up-->
 
<div class="1J1D8NGZC-20SQKFW-5M6" style="display:none;">
 
<div class="1J1D8NGZC-20SQKFW-5M6" style="display:none;">
 +
  
  
Line 831: Line 873:
 
</div>(...)<!--Pop-up for: Histone H2AX  Monoubiquitination !Pop-up-->
 
</div>(...)<!--Pop-up for: Histone H2AX  Monoubiquitination !Pop-up-->
 
<div class="1HXDX5TVJ-1TX6BB3-7JG" style="display:none;">
 
<div class="1HXDX5TVJ-1TX6BB3-7JG" style="display:none;">
 +
  
  
Line 837: Line 880:
 
</div>(...)<!--Pop-up for: Adducts with  transcription  factor Hif-1 !Pop-up-->
 
</div>(...)<!--Pop-up for: Adducts with  transcription  factor Hif-1 !Pop-up-->
 
<div class="1J1D8GLS6-N6V8MY-5GP" style="display:none;">
 
<div class="1J1D8GLS6-N6V8MY-5GP" style="display:none;">
 +
  
  
Line 843: Line 887:
 
</div>(...)<!--Pop-up for: Binding of Rb !Pop-up-->
 
</div>(...)<!--Pop-up for: Binding of Rb !Pop-up-->
 
<div class="1HXDY3B19-XD74WC-88N" style="display:none;">
 
<div class="1HXDY3B19-XD74WC-88N" style="display:none;">
 +
  
  
Line 849: Line 894:
 
</div>(...)<!--Pop-up for: Lysosomal degradation of EGF-R !Pop-up-->
 
</div>(...)<!--Pop-up for: Lysosomal degradation of EGF-R !Pop-up-->
 
<div class="1HXF40D8M-1LTSYPY-G1J" style="display:none;">
 
<div class="1HXF40D8M-1LTSYPY-G1J" style="display:none;">
 +
  
  
Line 855: Line 901:
 
</div>(...)<!--Pop-up for: DNA repair genes !Pop-up-->
 
</div>(...)<!--Pop-up for: DNA repair genes !Pop-up-->
 
<div class="1HXDXQ0P6-1FHWYSW-80J" style="display:none;">
 
<div class="1HXDXQ0P6-1FHWYSW-80J" style="display:none;">
 +
  
  
Line 861: Line 908:
 
</div>(...)<!--Pop-up for: Nucleoplasmin/B23 !Pop-up-->
 
</div>(...)<!--Pop-up for: Nucleoplasmin/B23 !Pop-up-->
 
<div class="1HXDY14S5-1LD6P1Q-86K" style="display:none;">
 
<div class="1HXDY14S5-1LD6P1Q-86K" style="display:none;">
 +
  
  
Line 867: Line 915:
 
</div>(...)<!--Pop-up for: ATM !Pop-up-->
 
</div>(...)<!--Pop-up for: ATM !Pop-up-->
 
<div class="1HXDXBJY6-2013R63-7PX" style="display:none;">
 
<div class="1HXDXBJY6-2013R63-7PX" style="display:none;">
 +
  
  
Line 873: Line 922:
 
</div>(...)<!--Pop-up for: E3 ubiquitin ligase MKRN1 !Pop-up-->
 
</div>(...)<!--Pop-up for: E3 ubiquitin ligase MKRN1 !Pop-up-->
 
<div class="1HXF0TRRP-14KR8HB-BJS" style="display:none;">
 
<div class="1HXF0TRRP-14KR8HB-BJS" style="display:none;">
 +
  
  
Line 879: Line 929:
 
</div>(...)<!--Pop-up for: Telomerase complex destruction !Pop-up-->
 
</div>(...)<!--Pop-up for: Telomerase complex destruction !Pop-up-->
 
<div class="1HXDZXGR8-11H1VXM-9RL" style="display:none;">
 
<div class="1HXDZXGR8-11H1VXM-9RL" style="display:none;">
 +
  
  
Line 885: Line 936:
 
</div>(...)<!--Pop-up for: E3 ubiquitin ligase Skp2 !Pop-up-->
 
</div>(...)<!--Pop-up for: E3 ubiquitin ligase Skp2 !Pop-up-->
 
<div class="1J2TTV0QY-1S75YF7-14X" style="display:none;">
 
<div class="1J2TTV0QY-1S75YF7-14X" style="display:none;">
 +
  
  
Line 891: Line 943:
 
</div>(...)<!--Pop-up for: Cellular senescence !Pop-up-->
 
</div>(...)<!--Pop-up for: Cellular senescence !Pop-up-->
 
<div class="1HXF423NB-1PLD05D-G51" style="display:none;">
 
<div class="1HXF423NB-1PLD05D-G51" style="display:none;">
 +
  
  
Line 897: Line 950:
 
</div>(...)<!--Pop-up for: Ubiquitination and proteasome  Degradation of cyclin D1 !Pop-up-->
 
</div>(...)<!--Pop-up for: Ubiquitination and proteasome  Degradation of cyclin D1 !Pop-up-->
 
<div class="1HXF2DVY7-2C75KYW-DK4" style="display:none;">
 
<div class="1HXF2DVY7-2C75KYW-DK4" style="display:none;">
 +
  
  
Line 903: Line 957:
 
</div>(...)<!--Pop-up for: Telomere lengthening !Pop-up-->
 
</div>(...)<!--Pop-up for: Telomere lengthening !Pop-up-->
 
<div class="1HXF23LXY-TG4R0T-CQW" style="display:none;">
 
<div class="1HXF23LXY-TG4R0T-CQW" style="display:none;">
 +
  
  
Line 909: Line 964:
 
</div>(...)<!--Pop-up for: High levels of glucose !Pop-up-->
 
</div>(...)<!--Pop-up for: High levels of glucose !Pop-up-->
 
<div class="1J1D89CBX-J65J0B-59H" style="display:none;">
 
<div class="1J1D89CBX-J65J0B-59H" style="display:none;">
 +
  
  
Line 915: Line 971:
 
</div>(...)<!--Pop-up for:  E3 ubiquitin ligase SCF-Skp2 !Pop-up-->
 
</div>(...)<!--Pop-up for:  E3 ubiquitin ligase SCF-Skp2 !Pop-up-->
 
<div class="1HXF1C9SL-1NY06WB-CBC" style="display:none;">
 
<div class="1HXF1C9SL-1NY06WB-CBC" style="display:none;">
 +
  
  
Line 921: Line 978:
 
</div>(...)<!--Pop-up for: Telomere shortening !Pop-up-->
 
</div>(...)<!--Pop-up for: Telomere shortening !Pop-up-->
 
<div class="1HXF24Q2K-K603LY-CSB" style="display:none;">
 
<div class="1HXF24Q2K-K603LY-CSB" style="display:none;">
 +
  
  
Line 927: Line 985:
 
</div>(...)<!--Pop-up for: SCF Fbx4/alphaB -crystalline E3 ubiquitin  ligase complex !Pop-up-->
 
</div>(...)<!--Pop-up for: SCF Fbx4/alphaB -crystalline E3 ubiquitin  ligase complex !Pop-up-->
 
<div class="1HXF1NHBS-1WFWH9C-CMN" style="display:none;">
 
<div class="1HXF1NHBS-1WFWH9C-CMN" style="display:none;">
 +
  
  

Revision as of 13:48, 26 February 2015

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.